This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q65379443
rdf:type
wikibase:Item
schema:description
ensayu clínicu klinisch onderzoek clinical trial клінічне випробування
rdfs:label
A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults
skos:prefLabel
A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults
schema:name
A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults
p:P1476
wds:Q65379443-F4F47A2C-68D8-4E57-B4A3-DCA573E2F79C
wdt:P1476
A Phase IV, Randomized, Observer-Blind, Placebo-Controlled, Multi-Centre Study to Evaluate the Efficacy, Safety and Tolerability of CSL Limited's Influenza Virus Vaccine in Adults Aged ≥ 18 to < 65 Years.
p:P582
wds:Q65379443-443BA9C1-2C96-4FB0-AF8F-1810A6261EF1
wdt:P582
2009-11-01T00:00:00Z
p:P31
wds:Q65379443-D1872FBB-5B02-4C35-9ADC-02C4701C351B
wdt:P31
wd:Q30612
p:P580
wds:Q65379443-9E2BD92A-519E-423C-83CB-9AC477CCA280
wdt:P580
2008-03-01T00:00:00Z
p:P17
wds:Q65379443-98A16A80-17AE-4F56-8F11-3E7D408F6556 wds:Q65379443-20BFC4D5-818A-4760-9948-E972A0D5A7B5
wdt:P17
wd:Q408 wd:Q664
p:P6153
wds:Q65379443-00C3D6AD-A502-40E1-AFBF-6E889303098B wds:Q65379443-ADD20137-4D6C-4EA0-B0E4-3B84F7A0ABD0 wds:Q65379443-FAADFED3-41CB-4167-BEB8-16C41F70C73F wds:Q65379443-FEE6EAC9-AC8D-4AB6-8C41-939A68C7A49E
wdt:P6153
wd:Q22669992 wd:Q7244698 wd:Q1202292 wd:Q492467
p:P1813
wds:Q65379443-F13D3D64-70D6-44C0-8F08-8006496C5C5F
wdt:P1813
CSL's IVV
p:P2899
wds:Q65379443-A4BF7751-CE86-4F6C-9774-1C951B69128C
wdt:P2899
18
p:P1132
wds:Q65379443-EB8E09F1-A553-4519-A86F-54F19DDA63AA
wdt:P1132
7500
p:P4135
wds:Q65379443-D8613A49-DFB4-468A-88FC-4486F103EAA5
wdt:P4135
64
p:P8363
wds:Q65379443-EDEA61B4-0277-4D6C-A040-4EFA85F06167
wdt:P8363
wd:Q78089383
p:P3098
wds:Q65379443-D47B58C1-ED9F-4DD3-852B-F21E0D0C6195
wdt:P3098
NCT00562484
p:P6099
wds:Q65379443-EB675A9A-3D7B-4617-94B3-ED90D9043942
wdt:P6099
wd:Q42825046